While COVID-19 has highlighted the invaluable nature of medical research, it has unfortunately also seriously disrupted it. In Australia, the sector now teeters on the brink of collapse.
Articles on Medical research Future fund
Displaying all articles
There are several areas where Australia could be a world leader in innovation. If we can identify them and focus our efforts there, we could generate some genuine benefits here and abroad.
The MRFF should prioritise the chances of making major advances in knowledge and the chances of research having an impact on Australian health and wealth.
If we want to boost innovation in this country, we should emulate a scheme that has proven highly successful in the United States.
Australian scientists are listened to by government and business, but must do more to ensure their advice and work contributes to a stronger future for Australia.
The big surprise about this year’s health budget was what wasn’t there – billions of dollars in expected savings from the Pharmaceutical Benefits Scheme.
In the government’s latest “scraping away the barnacles” of unpopular and blocked policies, prime minister Tony Abbott and health minister Peter Dutton have announced they’re abandoning the plan to have…
One of the most criticised components of the federal budget has been the proposed $7 co-payment for GP visits and some medical tests. But there’s a healthy way the treasurer can have his cake and eat it…
Medical research is a significant winner in the federal budget: we’re told, (probably falsely), that the government will establish the largest medical research fund in the world ($20 billion by 2023…
One of the few real surprises in the budget was the creation of medical research future fund, to be partly funded by the introduction of a $7 GP co-payment. This injection of money provides an opportunity…
The federal government has announced a $20 billion medical research future fund, which is expected to distribute $1 billion to research by 2022-23, doubling its direct medical research funding. The announcement…
Top contributors
-
Senior Lecturer in Ethics and Professionalism, Adelaide University
-
Professor of Health Policy, Curtin University
-
Emeritus Professor, Menzies Centre for Health Policy, University of Sydney
-
Professor of Health Economics, Duke-NUS Medical School
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Health Economics, The University of Melbourne
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Leeder Centre for Health Policy, Economics and Data & Sydney School of Public Health, University of Sydney
-
Chief Executive, CSIRO
-
President of the Australian Academy of Science, Laureate Professor Emeritus, The University of Melbourne
-
Professor of Statistics, Queensland University of Technology
-
Researcher, Queensland University of Technology
-
Adjunct professor, University of Canberra
-
Laureate Professor Emeritus, The Peter Doherty Institute for Infection and Immunity
-
Secretary-General, International Human Frontier Science Program Organisation; Emeritus Professor, Monash University, Monash University
-
Professor, John Curtin School of Medical Research, Australian National University